{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:45:48Z","timestamp":1784835948595,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.soc.2020.06.002","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T18:34:28Z","timestamp":1597084468000},"page":"603-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Updates in Staging and Management of Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"29","author":[{"given":"Andrea S.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja M.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2020.06.002_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jtcvs.2004.02.021","article-title":"Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies","volume":"128","author":"Sugarbaker","year":"2004","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.athoracsur.2010.04.110","article-title":"Characteristics of malignant pleural mesothelioma in women","volume":"90","author":"Wolf","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/ers.10.35","article-title":"Surgery for malignant pleural mesothelioma","volume":"4","author":"Sugarbaker","year":"2010","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.soc.2020.06.002_bib4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.athoracsur.2014.04.040","article-title":"Women with malignant pleural mesothelioma have a threefold better survival rate than men","volume":"98","author":"Taioli","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib5","first-page":"298","article-title":"Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy","volume":"40","author":"Sugarbaker","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib6","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1002\/cncr.32416","article-title":"Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma","volume":"125","author":"Chirieac","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2020.06.002_bib7","doi-asserted-by":"crossref","first-page":"e0145039","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients","volume":"10","author":"Taioli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.soc.2020.06.002_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jtcvs.2008.12.045","article-title":"Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors","volume":"138","author":"Yan","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/jso.24203","article-title":"Racial disparities in esophageal cancer survival after surgery","volume":"113","author":"Taioli","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib10","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/cncr.26553","article-title":"Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent","volume":"118","author":"Mayo","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2020.06.002_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.semtcvs.2009.07.002","article-title":"Recent advances in mesothelioma staging","volume":"21","author":"Richards","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thx.31.1.15","article-title":"Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients","volume":"31","author":"Butchart","year":"1976","journal-title":"Thorax"},{"key":"10.1016\/j.soc.2020.06.002_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1200\/JCO.1993.11.6.1172","article-title":"Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma","volume":"11","author":"Sugarbaker","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib15","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/cncr.24886","article-title":"Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases","volume":"116","author":"Richards","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2020.06.002_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jtho.2015.12.108","article-title":"A\u00a0novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis","volume":"11","author":"Brims","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib17","series-title":"TNM atlas","author":"(UICC) IUAC","year":"1992"},{"key":"10.1016\/j.soc.2020.06.002_bib18","series-title":"Fourth edition of the AJCC manual for staging of cancer","author":"Bears","year":"1992"},{"key":"10.1016\/j.soc.2020.06.002_bib19","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","article-title":"A\u00a0proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group","volume":"108","author":"Rusch","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.soc.2020.06.002_bib20","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jtho.2016.09.123","article-title":"The IASLC mesothelioma staging project: improving staging of a rare disease through international participation","volume":"11","author":"Pass","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib21","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/JTO.0000000000000181","article-title":"Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee","volume":"9","author":"Pass","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jtho.2019.04.029","article-title":"A\u00a0proposed system toward standardizing surgical-based treatments for malignant pleural mesothelioma, from the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce","volume":"14","author":"Friedberg","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2020.06.002_bib23","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.lungcan.2005.03.007","article-title":"The role of PET in the surgical management of malignant pleural mesothelioma","volume":"49","author":"Flores","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.soc.2020.06.002_bib24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jtcvs.2008.02.069","article-title":"The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system","volume":"136","author":"Flores","year":"2008","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/SLA.0000000000000903","article-title":"Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients","volume":"260","author":"Sugarbaker","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2214\/ajr.159.5.1414807","article-title":"Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability","volume":"159","author":"Patz","year":"1992","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.soc.2020.06.002_bib27","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/JTO.0b013e3181f1903e","article-title":"Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population","volume":"5","author":"Flores","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib28","doi-asserted-by":"crossref","first-page":"282145","DOI":"10.1155\/2015\/282145","article-title":"Frequency of surgery in black patients with malignant pleural mesothelioma","volume":"2015","author":"Taioli","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.soc.2020.06.002_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01243894-200605000-00004","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial","volume":"1","author":"Flores","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib30","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO.2004.10.071","article-title":"Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"22","author":"Weder","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib31","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.2005.04.6813","article-title":"Phase I to II study of pleurectomy\/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma","volume":"24","author":"Richards","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/BF02303746","article-title":"Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma","volume":"4","author":"Pass","year":"1997","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.06.002_bib33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib34","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1200\/JCO.2011.41.5869","article-title":"Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine\/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma","volume":"30","author":"Kindler","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.soc.2020.06.002_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.21037\/atm.2017.03.81","article-title":"Novel immunotherapy clinical trials in malignant pleural mesothelioma","volume":"5","author":"Tano","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.soc.2020.06.002_bib36","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"Flores","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.semtcvs.2009.07.007","article-title":"Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy\/decortication","volume":"21","author":"Wolf","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/thx.4.4.173","article-title":"Extrapleural pneumonectomy and pleurectomy in pulmonary tuberculosis","volume":"4","author":"Sarot","year":"1949","journal-title":"Thorax"},{"key":"10.1016\/j.soc.2020.06.002_bib39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtcvs.2012.12.037","article-title":"Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection","volume":"145","author":"Sugarbaker","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jtcvs.2009.02.046","article-title":"Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study","volume":"138","author":"Tilleman","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1010-7940(02)00273-7","article-title":"The management of malignant pleural mesothelioma; single centre experience in 10 years","volume":"22","author":"Aziz","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/JTO.0b013e31816fca1b","article-title":"Trimodality treatment of malignant pleural mesothelioma","volume":"3","author":"Batirel","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib43","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","article-title":"Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"18","author":"Weder","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib44","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib45","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1200\/JCO.2008.17.5604","article-title":"Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma","volume":"27","author":"de Perrot","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A\u00a0feasibility study evaluating surgery for mesothelioma after radiation therapy: the \"SMART\" approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2020.06.002_bib47","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jtcvs.2014.10.128","article-title":"Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma","volume":"149","author":"Baldini","year":"2015","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib48","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.semtcvs.2009.06.008","article-title":"Surgical options in malignant pleural mesothelioma: extrapleural pneumonectomy or pleurectomy\/decortication","volume":"21","author":"Flores","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib50","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0022-5223(19)38932-9","article-title":"Surgical treatment of pleural mesothelioma","volume":"84","author":"McCormack","year":"1982","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.soc.2020.06.002_bib51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jtcvs.2015.10.036","article-title":"Pleurectomy decortication for mesothelioma: the procedure of choice when possible","volume":"151","author":"Flores","year":"2016","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib52","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ijrobp.2005.03.041","article-title":"Hemithoracic radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma","volume":"63","author":"Gupta","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2020.06.002_bib53","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ijrobp.2011.09.027","article-title":"Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"83","author":"Rosenzweig","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2020.06.002_bib54","unstructured":"Wolf AS, Gill RR, Baldini EH, et\u00a0al. Patterns of recurrence following pleurectomy\/decortication for malignant pleural mesothelioma. 11th International Conference of the International Mesothelioma Interest Group:Boston, MA, USA;Sept. 12, 2012."},{"key":"10.1016\/j.soc.2020.06.002_bib55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jtcvs.2014.03.011","article-title":"Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality","volume":"148","author":"Burt","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lungcan.2013.11.026","article-title":"A\u00a0systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma","volume":"83","author":"Cao","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.soc.2020.06.002_bib57","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","article-title":"Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma","volume":"99","author":"Taioli","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib58","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ejcts.2009.10.020","article-title":"Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoring","volume":"37","author":"Wolf","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.soc.2020.06.002_bib59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.soc.2020.06.002_bib60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.21037\/atm.2017.04.05","article-title":"Randomized controlled trials in malignant pleural mesothelioma surgery\u2014mistakes made and lessons learned","volume":"5","author":"Waller","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.soc.2020.06.002_bib61","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.soc.2020.06.002_bib62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/path.5361","article-title":"CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness","volume":"250","author":"Inahuma","year":"2020","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.soc.2020.06.002_bib63","doi-asserted-by":"crossref","unstructured":"Desai A, Karrison T, Rose B, et\u00a0al. Phase II trial of pembrolizumab (NCT02399371) in previously-treated malignant mesothelioma (MM): final analysis. J Thorac Oncol 2018;13(10 Suppl).10.1016\/j.jtho.2018.08.277.","DOI":"10.1016\/j.jtho.2018.08.277"},{"key":"10.1016\/j.soc.2020.06.002_bib64","doi-asserted-by":"crossref","unstructured":"Desai A, Nakano T, Okada M, et\u00a0al. Long-term efficacy and safety of nivolumab in second-or third-line japanese malignant pleural mesothelioma patients (phase II: MERIT study). J Thorac Oncol 2018;13(10 Suppl). 10.1016\/j.jtho.2018.08.275.","DOI":"10.1016\/j.jtho.2018.08.275"},{"key":"10.1016\/j.soc.2020.06.002_bib65","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.soc.2020.06.002_bib66","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S1470-2045(16)30498-3","article-title":"Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study","volume":"17","author":"Langer","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320720300429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320720300429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:04:13Z","timestamp":1760961853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320720300429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1055320720300429"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2020.06.002","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in Staging and Management of Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2020.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}